In the absence of ARSI, this allows the AR cistrome to evolve and continue driving AR-dependent prostate cancer growth, while in the presence of ARSI this enables other transcription factors to rise in dominance and drive cancer progression. Here, ARSI is linked to prostate carcinoma.